Regencell Bioscience Holdings Ltd (RGC) — Capital Reinvestment Ratio
Regencell Bioscience Holdings Ltd (RGC) has a Capital Reinvestment Ratio of 0.49x as of December 2017, meaning it reinvests 0% of its operating cash flow ($154.30 Million) in capital expenditures ($74.90 Million). See Regencell Bioscience Holdings Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Regencell Bioscience Holdings Ltd Capital Reinvestment Ratio (2010–2018)
This chart tracks Regencell Bioscience Holdings Ltd's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Regencell Bioscience Holdings Ltd (2010–2018)
Year-by-year Capital Reinvestment Ratio for Regencell Bioscience Holdings Ltd from 2010 to 2018. For live market cap and broader valuation context, see Regencell Bioscience Holdings Ltd market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2018 | 0.61x | $409.90 Million | $250.40 Million | ▲ +16.7% |
| 2017 | 0.52x | $410.50 Million | $214.90 Million | ▲ +22.5% |
| 2016 | 0.43x | $434.40 Million | $185.70 Million | ▼ -4.8% |
| 2015 | 0.45x | $349.10 Million | $156.80 Million | ▲ +39.0% |
| 2014 | 0.32x | $346.90 Million | $112.10 Million | ▲ +25.6% |
| 2013 | 0.26x | $346.60 Million | $89.20 Million | ▲ +4.2% |
| 2012 | 0.25x | $353.10 Million | $87.20 Million | ▼ -34.9% |
| 2011 | 0.38x | $259.40 Million | $98.40 Million | ▲ +43.2% |
| 2010 | 0.26x | $410.80 Million | $108.80 Million | — |